4.6 Review

BMP signalling: agony and antagony in the family

Journal

TRENDS IN CELL BIOLOGY
Volume 25, Issue 5, Pages 249-264

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcb.2014.12.004

Keywords

bone morphogenetic proteins; antagonist; miRNA; Gremlin; disease

Categories

Funding

  1. Diabetes UK
  2. Northern Ireland Kidney Research Fund
  3. DEL Northern Ireland
  4. BBSRC CASE PhD studentship
  5. Irish Research Council for Science, Engineering, and Technology PhD programme in Bioinformatics and Systems Biology
  6. Science Foundation Ireland
  7. NIDDK Diabetes Complications Consortium
  8. Roche Pharmaceuticals, Basel

Ask authors/readers for more resources

Bone morphogenetic proteins (BMPs) are secreted extracellular matrix (ECM)-associated proteins that regulate a wide range of developmental processes, including limb and kidney formation. A critical element of BMP regulation is the presence of secreted antagonists that bind and inhibit BMP binding to their cognate Ser/Thr kinase receptors at the plasma membrane. Antagonists such as Noggin, Chordin, Gremlin (Grem1), and twisted gastrulation-1 (Twsg1) have been shown to inhibit BMP action in a range of different cell types and developmental stage-specific contexts. Here we review new developments in the field of BMP and BMP antagonist biology during mammalian development and suggest strategies for targeting these proteins in human disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available